Stroke–heart syndrome22 Nov 2018
In the latest podcast from The Lancet Neurology, Jan Scheitz discusses the development of stroke–heart syndrome.
Bruce Campbell joins The Lancet Neurology to discuss his systematic review of the HERMES collaboration.
Epileptic seizures16 Oct 2018
Mark Cook and Phillippa Karoly join The Lancet Neurology to discuss their retrospective study of cyclical patterns in epileptic seizures.
Bruce Trapp and Daniel Ontaneda discuss their retrospective study investigating cortical neuronal loss and cerebral white-matter demyelination in mulitple sclerosis.
Josep Dalmau joins The Lancet Neurology to discuss recognition and outcomes of autoimmune encephalitis after herpes simplex encephalitis.
Network imaging biomarkers16 Jun 2018
David Eidelberg and Katharina Schindelbeck join The Lancet Neurology to explain their new review of the applications of network imaging biomarkers in Parkinson's disease.
Eugene Major and David Clifford join The Lancet Neurology to discuss their review of pathogenesis and treatments for progressive multifocal leukoencephalopathy.
Torbjörn Tomson discusses the issue of antiepileptic drugs during pregnancy and the risk of major congenital malformations.
Christian Elger discusses the diagnostic challenges in epilepsy with the detection and reporting of seizures.
Jeffrey Cohen joins us to talk about the process of updating and revising the McDonald criteria for diagnosis of MS.
Jose Bras discusses his study of the genetic architecture of dementia with Lewy bodies.
Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.
Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.
Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.
Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease.
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy.
Eva Feldman discusses the neurological consequences of obesity.
Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases.
Randall Bateman and Nick Fox discuss what they've learned from their papers on Alzheimer's disease.
© 2009 - 2018 Ebling Library, UW-Madison
750 Highland Ave, Madison, WI, 53705-2221